Itolizumab (EQ001)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Itolizumab (EQ001), covering 2025-04-18 to 2025-04-18. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Itolizumab (EQ001) to Evaluate the Safety, Tolerability, PK, PD, and Clinical Activity in Uncontrolled Asthma [Phase 1]